ID: ALA4848027

Max Phase: Preclinical

Molecular Formula: C23H31N2O4P

Molecular Weight: 430.49

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1ccc(-c2ccccc2CN2CCP(=O)(O)[C@](CCCCN)(C(=O)O)C2)cc1

Standard InChI:  InChI=1S/C23H31N2O4P/c1-18-8-10-19(11-9-18)21-7-3-2-6-20(21)16-25-14-15-30(28,29)23(17-25,22(26)27)12-4-5-13-24/h2-3,6-11H,4-5,12-17,24H2,1H3,(H,26,27)(H,28,29)/t23-/m0/s1

Standard InChI Key:  ZKOBHVDVMWMQBZ-QHCPKHFHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 430.49

Molecular Weight (Monoisotopic): 430.2021

AlogP: 3.70

#Rotatable Bonds: 8

Polar Surface Area: 103.86

Molecular Species: ZWITTERION

HBA: 4

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 0.60

CX Basic pKa: 10.69

CX LogP: -3.79

CX LogD: -3.76

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.44

Np Likeness Score: -0.09

References

1. Schaffner AP, Sansilvestri-Morel P, Despaux N, Ruano E, Persigand T, Rupin A, Mennecier P, Vallez MO, Raimbaud E, Desos P, Gloanec P..  (2021)  Phosphinanes and Azaphosphinanes as Potent and Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa).,  64  (7.0): [PMID:33764059] [10.1021/acs.jmedchem.0c02072]

Source

Source(1):

• Scientific Literature